AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+16.3%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$5.04B
AUM Growth
+$522M
(+12%)
Cap. Flow
-$114M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
92.8%
Holding
109
New
12
Increased
18
Reduced
24
Closed
12
Top Buys
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$7.42M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$6.77M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$6.21M |
| 4 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$5.6M |
| 5 |
ProQR Therapeutics
PRQR
|
$4.85M |
Top Sells
| 1 |
Goldman Sachs
GS
|
$22.2M |
| 2 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$18.1M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$16.7M |
| 4 |
BLUE
bluebird bio
BLUE
|
$15.8M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
Sector Composition
| 1 | Consumer Staples | 49.27% |
| 2 | Consumer Discretionary | 25.43% |
| 3 | Healthcare | 24.54% |
| 4 | Financials | 0% |
| 5 | Industrials | 0% |